Arcutis Announces Pricing of $150 Million Public Offering
WESTLAKE VILLAGE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) a commercial-stage biopharmaceutical company focused on developing […]
CORRECTION – Monster Beverage Reports 2023 Fourth Quarter and Full-Year Financial Results
CORONA, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Press release amended to reflect a correction of the gross profit number […]
Tyson Foods, Inc. Announces Pricing of Senior Notes Offerings
SPRINGDALE, Ark., Feb. 28, 2024 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (the “Company”) (NYSE: TSN) announced today that it has […]
Portillo’s Inc. Announces Pricing of Offering of Class A Common Stock in “Synthetic Secondary” Transaction
CHICAGO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Portillo’s Inc. (“Portillo’s” or the “Company”) (Nasdaq: PTLO), the fast-casual restaurant concept known […]
Canadian Spirit Resources Inc. Announces The Second Quarter December 31, 2023 Financial Results
CALGARY, Alberta, Feb. 28, 2024 (GLOBE NEWSWIRE) — Canadian Spirit Resources Inc. (“CSRI” or the “Corporation”) (TSXV:SPI) (OTCBB:CSPUF) announces the […]
Williams Rowland Acquisition Corp. Announces Liquidation Price
Westport, CT, Feb. 28, 2024 (GLOBE NEWSWIRE) — Williams Rowland Acquisition Corp. (NYSE American: WRAC) (the “Company”), a publicly-traded special […]
Rubicon Organics Brings 1964 Supply Co. Cannabis-Infused Poutine Sauce to Quebec
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or […]
XPENG and the Volkswagen Group Announce Entry into Master Agreement on Strategic Technical Collaboration and Joint Sourcing Program
XPENG and the Volkswagen Group entered into Master Agreement on Platform and Software strategic technical collaboration XPENG and the Volkswagen […]
Sotera Health Announces Pricing of Secondary Offering
CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its […]
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total […]
